title: Pharmacological Treatments for Autism Spectrum Disorder: Will Emerging Approaches Yield New Treatments?
authors.affiliation: Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.|Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: Rocco G
authors.initials: RG
authors.lastname: Gogliotti
authors.affiliation: Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.|Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: P Jeffrey
authors.initials: PJ
authors.lastname: Conn
mesh_terms: D000818:Animals; D000067877:Autism Spectrum Disorder / Q000235:genetics* / Q000378:metabolism / Q000628:therapy*; D016503:Drug Delivery Systems / Q000639:trends*; D015316:Genetic Therapy / Q000639:trends*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology / Q000627:therapeutic use; D064529:Receptor, Metabotropic Glutamate 5 / Q000037:antagonists & inhibitors / Q000378:metabolism; D018080:Receptors, GABA-B / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: C578935:GRM5 protein, human; C583557:IGF1 protein, human; D064529:Receptor, Metabotropic Glutamate 5; D018080:Receptors, GABA-B; D007334:Insulin-Like Growth Factor I